LEVERAGE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Euronext Paris 12:30:00 2024-05-24 EDT | ||
| 51.84 EUR | -2.96% |
|
| Current month | -9.06% | ||
| 1 month | -10.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 51.6 | -3.41% |
| 24-05-23 | 53.42 | -1.73% |
| 24-05-22 | 54.36 | +0.78% |
| 24-05-21 | 53.94 | -9.93% |
| 24-05-20 | 59.89 | -2.44% |
Real-time Euronext Paris
Last update May 24, 2024 at 12:30 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
Société Générale
|
| 3J13S | |
| ISIN | DE000SV66V25 |
| Date issued | 2023-06-08 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50.59 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 73.14 € |
|---|---|
| Lowest since issue | 40.17 € |
| Spread | 1.22 € |
| Spread % | 2.33% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.34
EUR
Average target price
52.24
EUR
Spread / Average Target
+8.07%
- Stock Market
- Certificates
- 3J13S Certificat
